Additionally, a CRISPR/Cas9 based SEC62 knockout HNSCC cell line was generated and functionally characterized for its relevance in cell proliferation, migration as well as sensitivity to a SEC62 targeted therapy in vitro. This evidence concerns the gene SEC62 and head and neck squamous cell carcinoma.